Skip to content
Menu

Nektar Therapeutics NKTR

Full chart Compare
Set alert

Price alert · NKTR

All alert types
30.20 USD -2.34 (-7.19%)

Regular-session close

30.20 0.00 0.00%

After hours · Nov 20, 4:38 PM ET

30.13 Day range 32.35
30.13 52-week range 109.00
YTD
-28.57%
1 year
-45.20%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Income Tax Benefit$138.00KGross Profit$55.23MNet Loss$164.08MExpenses$219.45MSelling, General & Admin$68.67MResearch & Development$117.33MInterest Expense$26.18MOther Expenses$7.26MRevenue$55.23MNon Cash Royalty Revenue Related To Sale Of Future Royalties$54.93MLicense Collaboration And Other Revenue$300.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

NKTR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
55.23M98.43M90.12M92.06M101.91M
55.23M98.43M90.12M92.06M101.91M
55.23M67.74M56.35M70.42M77.01M
195.33M172.94M320.04M446.59M523.11M
117.33M120.91M114.16M218.32M400.27M
68.67M76.75M77.42M92.33M122.84M
-140.10M-105.20M-263.68M-376.17M-446.10M
26.18M28.11M25.33M28.91M47.31M
-138.00K-239.00K-200.00K3.21M557.00K
-164.08M-118.96M-276.06M-368.20M-523.84M
-164.08M-118.96M-276.06M-368.20M-523.84M
-164.08M-118.96M-276.06M-368.20M-523.84M
-164.08M-118.96M-276.06M-368.20M-523.84M
-9.73-8.68-21.70-29.50-42.90
-9.73-8.68-21.70-29.50-42.90
-9.73-8.68-21.70-29.50-42.90
-138.03M-91.09M-250.92M-336.07M-475.97M
-138.03M-91.09M-250.92M-336.07M-475.97M
16.87M13.71M12.67M12.48M12.22M
16.87M13.71M12.67M12.48M12.22M